Atossa Therapeutics
ATOS
#9991
Rank
S$58.44 M
Marketcap
S$6.79
Share price
-0.74%
Change (1 day)
508.72%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -S$39.57 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$32.48 Million, an increase over its 2023 earnings that were of -S$38.32 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$39.57 Million21.85%
2024 -S$32.48 Million-15.25%
2023 -S$38.32 Million11.62%
2022 -S$34.33 Million30.84%
2021 -S$26.24 Million15.58%
2020 -S$22.71 Million3.41%
2019 -S$21.96 Million51.16%
2018 -S$14.53 Million40.41%
2017 -S$10.35 Million27.54%
2016 -S$8.11 Million-47.49%
2015 -S$15.45 Million-17.25%
2014 -S$18.67 Million35.91%
2013 -S$13.74 Million112.3%
2012 -S$6.47 Million46.53%
2011 -S$4.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$42.72 B-111,272.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$1.67 B-4,467.13%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$1.69 B-4,512.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
S$53.07 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-S$0.14 Billion 252.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-S$9.99 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA